The Effects of Instrument-Assisted Soft Tissue Mobilization in Sedentary Individuals With Hamstri… (NCT07091383) | Clinical Trial Compass
CompletedNot Applicable
The Effects of Instrument-Assisted Soft Tissue Mobilization in Sedentary Individuals With Hamstring Tightness
Turkey (Türkiye)51 participantsStarted 2022-04-11
Plain-language summary
The aim of this study will be to investigate and compare the effects of static stretching exercise, Instrument Assisted Soft Tissue Mobilization (IASTM), and functional IASTM techniques on hamstring muscle shortness, pain threshold, skinfold thickness, and functional muscle strength in sedentary individuals. Fifty-one sedentary individuals between the ages of 18 and 45 who meet the inclusion criteria of Cyprus International University will be included in the study. The first group will receive static stretching exercises two days a week for four weeks; the second group will receive the IASTM technique two days a week for four weeks; and the third group will receive the functional IASTM technique, which will be applied with passive movements two days a week for four weeks. Hamstring shortness, pain threshold, skinfold thickness, and functional muscle strength will be evaluated before the treatment (BT), immediately after the treatment (AT1), two weeks after the treatment (AT2), and four weeks after the treatment (AT4).
Who can participate
Age range
18 Years – 45 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Sedentary individuals aged 18 to 45
* Who worked at a desk for extended periods
* Who exhibited hamstring muscle tightness of more than 10 degrees
Exclusion Criteria:
* Diagnosed orthopaedic or neurological disorder
* a history of lower limb surgery
* The presence of scoliosis
* Tightness in the gastrocnemius muscle
* Participants who did not consistently attend the intervention programme (i.e., those who missed two or more sessions out of the 12 sessions)
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.